Curetis GmbH

Curetis GmbH is a subsidiary of OpGen, Inc. an international company for precision medicine.

Curetis makes use of the possibilities of molecular diagnostics and computer science to combat infectious diseases. Together with the other OpGen subsidiary Ares Genetics GmbH and additional partners in the InfectoGnostics research campus, bioinformatics and sequencing services are used for the prediction of antibiotic resistance and further developed into molecular diagnostic on-site tests – for example in the campus project PREPLEX.

Such point-of-care solutions enable clinicians to quickly obtain easily usable information about life-threatening, multi-resistant infectious pathogens and thus to initiate effective treatment of patients at an early stage.


Curetis GmbH

Max-Eyth-Str. 42
71088 Holzgerlingen